Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Evoked Myogenic Potentials | 4 | 2022 | 5 | 0.500 |
Why?
|
| Vestibule, Labyrinth | 5 | 2013 | 14 | 0.460 |
Why?
|
| Acoustic Stimulation | 5 | 2022 | 93 | 0.350 |
Why?
|
| Otolithic Membrane | 3 | 2022 | 3 | 0.240 |
Why?
|
| Neck Muscles | 2 | 2016 | 5 | 0.210 |
Why?
|
| Oculomotor Muscles | 2 | 2010 | 20 | 0.170 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 292 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2015 | 68 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2015 | 124 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2022 | 1534 | 0.110 |
Why?
|
| Surgical Flaps | 2 | 2006 | 110 | 0.110 |
Why?
|
| Sound | 1 | 2013 | 10 | 0.110 |
Why?
|
| Neurons, Afferent | 1 | 2013 | 20 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2015 | 127 | 0.100 |
Why?
|
| Mastoid | 1 | 2012 | 51 | 0.090 |
Why?
|
| Rats | 6 | 2022 | 3146 | 0.090 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 24 | 0.090 |
Why?
|
| Vestibular Nuclei | 1 | 2010 | 6 | 0.080 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2010 | 5 | 0.080 |
Why?
|
| Wakefulness | 1 | 2010 | 47 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2010 | 90 | 0.080 |
Why?
|
| Electromyography | 1 | 2010 | 127 | 0.080 |
Why?
|
| Animals | 10 | 2022 | 13332 | 0.080 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2008 | 1 | 0.070 |
Why?
|
| Nystagmus, Physiologic | 1 | 2008 | 3 | 0.070 |
Why?
|
| Fixation, Ocular | 1 | 2008 | 12 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 50 | 0.070 |
Why?
|
| Bone Substitutes | 1 | 2007 | 8 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 808 | 0.060 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2006 | 14 | 0.060 |
Why?
|
| Male | 12 | 2016 | 26652 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 187 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2012 | 1699 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2004 | 15 | 0.050 |
Why?
|
| Rectus Abdominis | 1 | 2004 | 10 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 1467 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2007 | 492 | 0.050 |
Why?
|
| Acoustics | 1 | 2022 | 17 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 332 | 0.040 |
Why?
|
| Models, Animal | 2 | 2013 | 228 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 1418 | 0.040 |
Why?
|
| Reference Values | 2 | 2010 | 313 | 0.030 |
Why?
|
| Adult | 4 | 2016 | 14095 | 0.030 |
Why?
|
| Posture | 1 | 2016 | 66 | 0.030 |
Why?
|
| Bacillus Phages | 1 | 2015 | 2 | 0.030 |
Why?
|
| RNA Stability | 1 | 2015 | 24 | 0.030 |
Why?
|
| Folate Receptor 1 | 1 | 2015 | 27 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 210 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 132 | 0.030 |
Why?
|
| Base Sequence | 1 | 2015 | 627 | 0.030 |
Why?
|
| Semicircular Canals | 1 | 2013 | 12 | 0.030 |
Why?
|
| Action Potentials | 1 | 2013 | 114 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 2970 | 0.030 |
Why?
|
| Mice | 2 | 2015 | 5877 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 207 | 0.020 |
Why?
|
| Saccule and Utricle | 1 | 2012 | 2 | 0.020 |
Why?
|
| Humans | 6 | 2016 | 52114 | 0.020 |
Why?
|
| Paxillin | 1 | 2012 | 4 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 12 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2012 | 14 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2012 | 19 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 31 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 108 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2011 | 10 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 231 | 0.020 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 4 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 216 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 853 | 0.020 |
Why?
|
| Caloric Tests | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrooculography | 1 | 2010 | 12 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2010 | 28 | 0.020 |
Why?
|
| Electrodes | 1 | 2010 | 34 | 0.020 |
Why?
|
| Eye Movements | 1 | 2010 | 21 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 343 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2010 | 93 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 731 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 624 | 0.020 |
Why?
|
| Female | 3 | 2016 | 28055 | 0.020 |
Why?
|
| Dominance, Ocular | 1 | 2008 | 1 | 0.020 |
Why?
|
| Vestibular Function Tests | 1 | 2008 | 7 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2008 | 29 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 164 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2007 | 16 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2006 | 33 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4307 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2006 | 43 | 0.020 |
Why?
|
| Necrosis | 1 | 2006 | 169 | 0.020 |
Why?
|
| Rabbits | 1 | 2006 | 371 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 1665 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2282 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2004 | 8 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 171 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 181 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 158 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 554 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 580 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 871 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 975 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1135 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 13028 | 0.010 |
Why?
|